H1N1 vaccine safety monitoring: beyond background rates
Authors:
- 1 April 2010
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 375 (9721) , 1146-1147
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccinesThe Lancet, 2009
- Real-Time Vaccine Safety Surveillance for the Early Detection of Adverse EventsMedical Care, 2007
- The Role of the Vaccine Adverse Event Reporting System (VAERS) in Monitoring Vaccine SafetyPediatric Annals, 2004
- The Vaccine Safety Datalink projectPharmacoepidemiology and Drug Safety, 2001